Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 272

Similar articles for PubMed (Select 15191033)

1.

PDE4 inhibitors in COPD--a more selective approach to treatment.

Vignola AM.

Respir Med. 2004 Jun;98(6):495-503. Review.

PMID:
15191033
2.
3.

Selective phosphodiesterase-4 inhibitors in chronic obstructive lung disease.

Soto FJ, Hanania NA.

Curr Opin Pulm Med. 2005 Mar;11(2):129-34. Review.

PMID:
15699784
4.

Phosphodiesterase inhibitors in airways disease.

Fan Chung K.

Eur J Pharmacol. 2006 Mar 8;533(1-3):110-7. Epub 2006 Feb 2. Review.

PMID:
16458289
5.

[Selective phosphodiesterase-4 (PDE-4) inhibitors in COPD].

Tatlicio─člu T.

Tuberk Toraks. 2008;56(4):472-84. Review. Turkish.

PMID:
19123088
6.

Cilomilast.

Schachter EN.

Drugs Today (Barc). 2006 Apr;42(4):237-47. Review.

PMID:
16703120
7.

Roflumilast for the treatment of chronic obstructive pulmonary disease.

Antoniu SA.

Curr Opin Investig Drugs. 2006 May;7(5):412-7. Review.

PMID:
16729716
8.

The potential role of roflumilast: the new phosphodiesterase-4 inhibitor.

Karish SB, Gagnon JM.

Ann Pharmacother. 2006 Jun;40(6):1096-104. Epub 2006 May 30. Review.

PMID:
16735669
9.

Cilomilast: orally active selective phosphodiesterase-4 inhibitor for treatment of chronic obstructive pulmonary disease.

Martina SD, Ismail MS, Vesta KS.

Ann Pharmacother. 2006 Oct;40(10):1822-8. Epub 2006 Sep 19. Review.

PMID:
16985092
10.

Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease.

Lipworth BJ.

Lancet. 2005 Jan 8-14;365(9454):167-75. Review.

PMID:
15639300
11.

Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4.

Rennard SI, Schachter N, Strek M, Rickard K, Amit O.

Chest. 2006 Jan;129(1):56-66.

PMID:
16424413
12.

PDE4 inhibitors as new anti-inflammatory drugs: effects on cell trafficking and cell adhesion molecules expression.

Sanz MJ, Cortijo J, Morcillo EJ.

Pharmacol Ther. 2005 Jun;106(3):269-97. Epub 2005 Feb 25. Review.

PMID:
15922015
13.

[Phosphosdiesterase 4 inhibitors in the treatment of pulmonary diseases].

Xia XD, Dai YR, Xu ZJ.

Zhonghua Jie He He Hu Xi Za Zhi. 2004 Jan;27(1):57-9. Review. Chinese. No abstract available.

PMID:
14989829
14.
15.

Roflumilast: a selective phosphodiesterase 4 inhibitor.

Christie P.

Drugs Today (Barc). 2005 Oct;41(10):667-75. Review.

PMID:
16389409
16.

Phosphodiesterase-4 inhibitors as a novel approach for the treatment of respiratory disease: cilomilast.

Kroegel C, Foerster M.

Expert Opin Investig Drugs. 2007 Jan;16(1):109-24. Review.

PMID:
17155857
17.

In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor.

Bundschuh DS, Eltze M, Barsig J, Wollin L, Hatzelmann A, Beume R.

J Pharmacol Exp Ther. 2001 Apr;297(1):280-90.

18.

Are phosphodiesterase 4 inhibitors just more theophylline?

Boswell-Smith V, Cazzola M, Page CP.

J Allergy Clin Immunol. 2006 Jun;117(6):1237-43. Epub 2006 May 3. Review.

PMID:
16750981
19.

PDE4 inhibition: a novel approach for the treatment of inflammatory bowel disease.

Banner KH, Trevethick MA.

Trends Pharmacol Sci. 2004 Aug;25(8):430-6. Review.

PMID:
15276712
20.

Phosphodiesterase 4 inhibitors for the treatment of COPD.

Sturton G, Fitzgerald M.

Chest. 2002 May;121(5 Suppl):192S-196S. Review.

PMID:
12010850
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk